SELANK 10mg from Adaptog Peptides is a synthetic heptapeptide based on the human tuftsin sequence, widely used in research on anxiolytic-like signalling, immune modulation, and cognitive performance. Investigators value SELANK for its documented influence on enkephalin systems and balanced neurochemical activity. Adaptog supplies SELANK 10mg as a high-purity reagent for controlled, reproducible laboratory work.
SELANK occupies a distinctive place in peptide research thanks to its multi-system activity profile. Studies have explored its effects on monoamine pathways, enkephalinase inhibition, and immune-related cytokine signalling, making it a versatile tool for investigators working across neuroscience and psychoneuroimmunology. Adaptog Peptides supplies SELANK 10mg at consistent purity to support reliable experimental outcomes.
Researchers often buy SELANK 10mg from Adaptog Peptides for projects such as:
Investigating anxiolytic-like signalling in controlled behavioural models
Examining enkephalin-system modulation and peptidase activity
Studying serotonergic and dopaminergic interactions
Exploring cytokine balance in psychoneuroimmunology research
Because SELANK bridges neurochemistry, behaviour, and immune-system research, it supports a broad range of investigative work. Adaptog Peptides delivers SELANK 10mg as a laboratory reagent prepared strictly for qualified research environments. It is not intended for clinical, diagnostic, or therapeutic application.
For research use only. Not for human consumption.
SELANK occupies a distinctive place in peptide research thanks to its multi-system activity profile. Studies have explored its effects on monoamine pathways, enkephalinase inhibition, and immune-related cytokine signalling, making it a versatile tool for investigators working across neuroscience and psychoneuroimmunology. Adaptog Peptides supplies SELANK 10mg at consistent purity to support reliable experimental outcomes.
Researchers often buy SELANK 10mg from Adaptog Peptides for projects such as:
Investigating anxiolytic-like signalling in controlled behavioural models
Examining enkephalin-system modulation and peptidase activity
Studying serotonergic and dopaminergic interactions
Exploring cytokine balance in psychoneuroimmunology research
Because SELANK bridges neurochemistry, behaviour, and immune-system research, it supports a broad range of investigative work. Adaptog Peptides delivers SELANK 10mg as a laboratory reagent prepared strictly for qualified research environments. It is not intended for clinical, diagnostic, or therapeutic application.
For research use only. Not for human consumption.
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥99% |
| Form | Lyophilized powder |
-20°C · 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | GLP3-RT 10mg |
|---|---|
| Lot # | REF0001 |
| Labeled | 20mg |
| Actual | 22.61mg |
| Tested | APR 15, 2026 |
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Not a researcher? Exit
